Continuing Medical Education (CME) Credits
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Upon completion of this program, participants should be able to:
- Discuss preoperative diagnosis and monitoring tips while focusing on disease progression in glaucoma patients.
- Examine the essentials of testing and traditional medical management.
- Illustrate case-based studies that highlight the various uses of laser delivery and drug therapy in Glaucoma Care.
- Assess the landscape of surgical intervention for Glaucoma patients and add-on surgical intervention as part of cataract surgery.
- Compare the various MIGS approaches now and in the pipeline for Glaucoma treatment.
Claim CME/CE Credits
Attendees will be able to evaluate this webinar electronically. At the conclusion of the program, attendees follow the link to the program evaluation and credit claim. Please contact Janell John, ASCRS CME Coordinator, at firstname.lastname@example.org with any questions on credit claims.
Scientific Integrity and Financial Interest Disclosure
Financial Interest Disclosures for all faculty are available within the Financial Interest section of the Glaucoma Building Blocks website. ASCRS is committed to ensuring that all continuing medical education (CME) information is based on the application of research findings and the implementation of evidence-based medicine. ASCRS seeks to promote balance, objectivity and absence of commercial bias in its content. All persons in a position to control the content of this activity must disclose all relevant financial interests. ASCRS has mechanisms in place to mitigate all conflicts of interest prior to an educational activity being delivered to learners.
Notice About Off-Label Use Presentations
The webinar may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.